Visit-to-Visit Variability in Blood Pressure as a Predictor of Poor Cognitive Function
BPV-COG
Multicenter Retrospective Study of Visit-to-Visit Variability in Blood Pressure as a Predictor of Poor Cognitive Function
1 other identifier
observational
140
1 country
5
Brief Summary
Hypertension in midlife is an independent risk factor of late life cognitive dysfunction or dementia. Chronic hypertension cause vascular damage and cerebral ischemia, which ultimately gives rise to the cognitive dysfunction or dementia. A recent study showed that high visit-to-visit variability in clinic systolic blood pressure (BP) was a strong independent predictor of stroke. This finding suggests that high clinic systolic BP variability itself as well as chronic hypertension may cause vascular damage and cerebral ischemia. Therefore, high clinic SBP variability may be also an independent risk factor of cognitive dysfunction or dementia. Vascular damage leads to the diminished autoregulatory capacities of cerebral arteries. The brain with the reduced autoregulatory capacity may be more vulnerable to BP fluctuation. Therefore, high BP variability may be more harmful in patients with damaged vessels (for example, in patients with cerebral small vessel disease). Previous data about BP variability and cognition revealed very controversial. Some studies showed poor cognition in patients with high BP variability, but others did not. The previous studies were mostly based on cross-sectional designs, and performed in small-sized heterogeneous population for primary prevention. The harmful effect of high BP variability may be clearer in the population with damaged vascular bed, such as cerebral small vessel disease. The previous studies usually used ambulatory BP monitoring (ABPM). However, recent data suggested that variability in BP on ABPM may be a weaker predictor of vascular events than be visit-to-visit variability in clinic BP. The investigators sought to find whether high visit-to-visit variability in clinic BP is related with poor cognitive function in patients with cerebral small vessel disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2012
Shorter than P25 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 16, 2012
CompletedFirst Posted
Study publicly available on registry
September 20, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2013
CompletedSeptember 20, 2012
September 1, 2012
9 months
September 16, 2012
September 19, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Association between raw score of K-MMSE and visit-to-visit systolic BP variability
Difference of mean K-MMSE raw scores between the highest and the lowest tertile group stratified by visit-to-visit systolic BP variability: Wilcoxon\_Mann\_Whitney test Binary logistic regression analysis for independent association between visit-to-visit systolic BP variability and low cognition, including confounding variables with p\<0.2 in univariate analysis (Low cognition, defined as the lowest tertile of K-MMSE raw score)
Time from previous MRI documentation as small vessel disease to cognitive function evaluation; 1.5 to 7 years
Secondary Outcomes (3)
Association between raw score of K-MMSE and visit-to-visit diastolic BP variability
Time from previous MRI documentation as small vessel disease to cognitive function evaluation; 1.5 to 7 years
Association between raw scores of "K-VCI NP 30-minute protocol" sub-tests and visit-to-visit systolic BP variability
Time from previous MRI documentation as small vessel disease to cognitive function evaluation; 1.5 to 7 years
Association between raw scores of "K-VCI NP 30-minute protocol" sub-tests and visit-to-visit diastolic BP variability
Time from previous MRI documentation as small vessel disease to cognitive function evaluation; 1.5 to 7 years
Study Arms (1)
Visit-to-visit BP variability
The highest, intermediate, and the lowest visit-to-visit BP variability (Tertile grouping)
Eligibility Criteria
Outpatients of stroke clinic in secondary or tertiary hospitals
You may qualify if:
- Patients with cerebral small vessel disease previously documented on MRI (definition of small vessel disease - symptomatic lacunar infarction or white matter ischemic lesion with one or more asymptomatic lacunes)
You may not qualify if:
- Incomplete clinic BP data (less than 6 BP readings during recent one year)
- History of cardiovascular or cerebrovascular events during recent one year
- Documented cerebral infarction from large artery atherosclerosis
- Atrial fibrillation or cardiac disease with high risk of embolism
- Significant medical, neurological, or psychiatric disease affecting cognition
- Known dementia treated with acetylcholine esterase inhibitor or memantine
- Patients without informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Chuncheon Sacred Heart Hospital, Hallym University, College of Medicine
Chuncheon, Gangwon-do, 200-704, South Korea
Hallym University Sacred Heart Hospital, Hallym University, College of Medicine
Anyang-si, Gyeonggi-do, 431-796, South Korea
Gangdong Sacred Heart Hospital, Hallym University, College of Medicine
Seoul, 134-701, South Korea
Hangang Sacred Heart Hospital, Hallym University, College of Medicine
Seoul, 150-719, South Korea
Gangnam Sacred Heart Hospital, Hallym University, College of Medicine
Seoul, 150-950, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 16, 2012
First Posted
September 20, 2012
Study Start
May 1, 2012
Primary Completion
February 1, 2013
Study Completion
February 1, 2013
Last Updated
September 20, 2012
Record last verified: 2012-09